- A Case of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease
-
Seok J, Suk KT, Kim DJ
- KMID: 2409648
- J Liver Cancer.
- 2018 Mar;18(1):51-54.
- doi: 10.17998/jlc.18.1.51
Non-alcoholic fatty liver disease (NAFLD) has been one of the causes of cryptogenic hepatocellular carcinoma (HCC). NAFLD-associated HCC (NAFLD-HCC) have clinical features such as high body mass index, deranged lipid... -
- CITED
-
- Close
- SHARE
-
- Close
- Are patients with alcohol-related fatty liver at increased risk of coronary heart disease?
-
Sinn DH, Paik YH
- KMID: 1788563
- Clin Mol Hepatol.
- 2014 Jun;20(2):151-153.
- doi: 10.3350/cmh.2014.20.2.151
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Histologic Risk Factor for Mortality and Development of Severe Liver Disease in Biopsy-proven Non-alcoholic Fatty Liver Disease
-
Park JW, Park JY
- KMID: 2402808
- Korean J Gastroenterol.
- 2018 Jan;71(1):58-60.
- doi: 10.4166/kjg.2018.71.1.58
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?
-
Cho YK
- KMID: 2428757
- Clin Mol Hepatol.
- 2018 Sep;24(3):299-301.
- doi: 10.3350/cmh.2018.1006
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnosis of Non-Alcoholic Fatty Liver Disease Based on Clinical and Laboratory Data
-
Lee YH
- KMID: 2385571
- J Korean Diabetes.
- 2017 Jun;18(2):102-108.
- doi: 10.4093/jkd.2017.18.2.102
Non-alcoholic fatty liver disease (NAFLD) is one of the most common metabolic liver disorders, and its incidence is expected to increase rapidly in the future as the rate of obesity... -
- CITED
-
- Close
- SHARE
-
- Close
- Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease
-
Kim HS, Cho YK
- KMID: 2384359
- Korean J Gastroenterol.
- 2017 Jun;69(6):333-340.
- doi: 10.4166/kjg.2017.69.6.333
Non-alcoholic fatty liver disease (NAFLD) includes a wide spectrum of diseases that range from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis. In addition, the burden of NAFLD is rapidly... -
- CITED
-
- Close
- SHARE
-
- Close
- Implications of Mitochondrial Unfolded Protein Response and Mitokines: A Perspective on Fatty Liver Diseases
-
Yi HS
- KMID: 2441677
- Endocrinol Metab.
- 2019 Mar;34(1):39-46.
- doi: 10.3803/EnM.2019.34.1.39
The signaling network of the mitochondrial unfolded protein response (UPR(mt)) and mitohormesis is a retrograde signaling pathway through which mitochondria-to-nucleus communication occurs in organisms. Recently, it has been shown that... -
- CITED
-
- Close
- SHARE
-
- Close
- The Risk of Abdominal Obesity according to the Degree of Non-Alcoholic Fatty Liver Disease in Korean Men
-
Park SK, Ryoo JH, Choi JM, Seo MW, Park CM
- KMID: 2363502
- J Korean Med Sci.
- 2016 Mar;31(3):410-416.
- doi: 10.3346/jkms.2016.31.3.410
Although non-alcoholic fatty liver disease has been reported as a cardiometabolic risk factor, the effect of non-alcoholic fatty liver is yet to be clarified on abdominal obesity. Therefore, this study... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease
-
Jeong WK
- KMID: 2389344
- Gut Liver.
- 2017 Sep;11(5):577-578.
- doi: 10.5009/gnl17333
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease
-
Kim MY
- KMID: 2384360
- Korean J Gastroenterol.
- 2017 Jun;69(6):341-347.
- doi: 10.4166/kjg.2017.69.6.341
Understanding the pathogenesis of non-alcoholic steatohepatitis (NASH) and its fibrosis progression is still evolving. Nonetheless, current evidence suggests that mechanisms involved are very complex parallel processes with multiple metabolic factors.... -
- CITED
-
- Close
- SHARE
-
- Close
- Sex Difference in the Association between Serum Homocysteine Level and Non-Alcoholic Fatty Liver Disease
-
Won BY, Park KC, Lee SH, Yun SH, Kim MJ, Park KS, Kim YS, Haam JH, Kim HY, Kim HJ, Park KH
- KMID: 2391714
- Korean J Fam Med.
- 2016 Jul;37(4):242-247.
- doi: 10.4082/kjfm.2016.37.4.242
BACKGROUND: The relationship between serum homocysteine levels and non-alcoholic fatty liver disease is poorly understood. This study aims to investigate the sex-specific relationship between serum homocysteine level and non-alcoholic fatty... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effects of Hypoglycemic Agents on Non-alcoholic Fatty Liver Disease: Focused on Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
-
Jung CH, Mok JO
- KMID: 2452623
- J Obes Metab Syndr.
- 2019 Mar;28(1):18-29.
- doi: 10.7570/jomes.2019.28.1.18
The only known, effective intervention for non-alcoholic fatty liver disease (NAFLD) is weight loss, and there is no approved pharmacotherapy. Recently, new hypoglycemic agents, such as sodium-glucose cotransporter 2 (SGLT2)... -
- CITED
-
- Close
- SHARE
-
- Close
- Tamoxifen-Induced Non-alcoholic Steatohepatitis Cirrhosis
-
Kim TH, Kim YB, Cheong JY, Cho SW, Kim SS
- KMID: 2437772
- Soonchunhyang Med Sci.
- 2018 Jun;24(1):81-84.
- doi: 10.0000/sms.2018.24.1.81
Non-alcoholic fatty liver disease has been observed in over 30% of patients who have received tamoxifen therapy. However, tamoxifen-induced non-alcoholic steatohepatitis (NASH) cirrhosis has never been reported in Korea. A... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
-
Patoulias , Imprialos , Stavropoulos K, Doumas M
- KMID: 2459795
- Clin Mol Hepatol.
- 2019 Sep;25(3):331-332.
- doi: 10.3350/cmh.2019.0034
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Nonalcoholic Fatty Liver Disease Is a Stepping Stone in the Path toward Diabetes Mellitus
-
Heo NY
- KMID: 2458519
- Gut Liver.
- 2019 Jul;13(4):383-384.
- doi: 10.5009/gnl19192
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- It's Ready for Targeting Muscle in Nonalcoholic Fatty Liver in This Era of Aging
-
Joo SK, Kim W
- KMID: 2434383
- Gut Liver.
- 2019 Jan;13(1):5-6.
- doi: 10.5009/gnl18483
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Obesity and Hepatocellular Carcinoma
-
Sohn W
- KMID: 2357337
- J Liver Cancer.
- 2016 Sep;16(2):86-91.
- doi: 10.17998/jlc.2016.16.2.86
Obesity is closely associated with hepatocellular carcinoma (HCC) as well as other malignancies. Obesity is an important risk factor for cancer development and overall mortality in HCC. Molecular mechanisms of... -
- CITED
-
- Close
- SHARE
-
- Close
- Novel Therapeutic Target of Non-alcoholic Fatty Liver Disease: Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 and Reactive Oxygen Species in Pro-inflammatory Macrophages
-
Eun HS
- KMID: 2424117
- Korean J Gastroenterol.
- 2018 Oct;72(4):226-227.
- doi: 10.4166/kjg.2018.72.4.226
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Skeletal Muscle Mass on Metabolic Health
-
Kim G, Kim JH
- KMID: 2471714
- Endocrinol Metab.
- 2020 Mar;35(1):1-6.
- doi: 10.3803/EnM.2020.35.1.1
Skeletal muscle is regarded as an endocrine and paracrine organ. Muscle-derived secretory proteins, referred to as myokines, mediate interactions between skeletal muscle mass and other organs such as the liver,... -
- CITED
-
- Close
- SHARE
-
- Close
- Non-alcoholic Fatty Liver Disease and Hepatocellular Carcinoma
-
Oh H, Jun DW
- KMID: 2396566
- J Liver Cancer.
- 2017 Sep;17(2):117-125.
- doi: 10.17998/jlc.17.2.117
Hepatocellular carcinoma (HCC) is one of the most common life-threatening cancers worldwide. Recently, many patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) have progressed to HCC even... -
- CITED
-
- Close
- SHARE
-
- Close
